DE19508628A1 - Skin moisturising cosmetics - Google Patents
Skin moisturising cosmeticsInfo
- Publication number
- DE19508628A1 DE19508628A1 DE1995108628 DE19508628A DE19508628A1 DE 19508628 A1 DE19508628 A1 DE 19508628A1 DE 1995108628 DE1995108628 DE 1995108628 DE 19508628 A DE19508628 A DE 19508628A DE 19508628 A1 DE19508628 A1 DE 19508628A1
- Authority
- DE
- Germany
- Prior art keywords
- miliacin
- millet
- cosmetics
- skin
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 13
- YZBNXQLCEJJXSC-LZBBLKFASA-N (3S,4aR,6aS,6aR,6bR,8aR,14aR,14bR)-3-methoxy-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,6a,7,8,9,10,13,14,14a-tetradecahydropicene Chemical compound C1([C@H]2CC[C@H]34)=CC(C)(C)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](OC)C1(C)C YZBNXQLCEJJXSC-LZBBLKFASA-N 0.000 claims abstract description 30
- DYWBABNJDLLCOR-UHFFFAOYSA-N Miliacin Natural products COC1CCC2(C)C3CCC4(C)C5=CC(C)(C)CCC5(C)CCC4(C)C3(C)CCC2(C)C1(C)C DYWBABNJDLLCOR-UHFFFAOYSA-N 0.000 claims abstract description 30
- YZBNXQLCEJJXSC-UHFFFAOYSA-N O-Methyl-germanicol Natural products C12CCC3C4=CC(C)(C)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(OC)C1(C)C YZBNXQLCEJJXSC-UHFFFAOYSA-N 0.000 claims abstract description 30
- 244000062793 Sorghum vulgare Species 0.000 claims description 18
- 235000019713 millet Nutrition 0.000 claims description 18
- 238000002360 preparation method Methods 0.000 claims description 10
- 239000004480 active ingredient Substances 0.000 claims description 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 3
- 239000013543 active substance Substances 0.000 abstract 1
- 239000012752 auxiliary agent Substances 0.000 abstract 1
- 239000003921 oil Substances 0.000 description 15
- 239000000203 mixture Substances 0.000 description 8
- 239000000126 substance Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 239000003995 emulsifying agent Substances 0.000 description 6
- 239000000839 emulsion Substances 0.000 description 4
- 239000003925 fat Substances 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 239000003906 humectant Substances 0.000 description 4
- 239000010903 husk Substances 0.000 description 4
- 238000004321 preservation Methods 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- -1 fatty acid esters Chemical class 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000000017 hydrogel Substances 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 244000078912 Trichosanthes cucumerina Species 0.000 description 1
- 235000008322 Trichosanthes cucumerina Nutrition 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000007957 coemulsifier Substances 0.000 description 1
- 229910052681 coesite Inorganic materials 0.000 description 1
- 229910052906 cristobalite Inorganic materials 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 229940057917 medium chain triglycerides Drugs 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000004789 organ system Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229910052682 stishovite Inorganic materials 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 229910052905 tridymite Inorganic materials 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
Description
Die Anwendung von Naturstoffen in der Kosmetik ist heutzutage auf die Vorbeugung von altersbedingten Hautveränderungen und Stärkung der Regenerationsvorgänge der Haut gerichtet. Der genaue Wirkungsmechanismus dieser Stoffe ist nicht mit letzter Sicherheit bewiesen. Es sind vielmehr Anwendungserfahrungen und Analogieschlüsse, die aus anderen Organsystemen abgeleitet werden, die zur Auswahl eines Naturstoffes in einer kosmetischen Zubereitung den Ausschlag geben. Aufgrund der Tatsache, daß Hirseextrakte und namentlich der wirksame Bestandteil, Miliacin, im Tierexperiment eine fördernde Wirkung bei Heilung von Wunden gezeigt haben führt uns zu der Annahme, daß die, im einzelnen bislang nicht geklärten, Eigenschaften auch in der kosmetischen Anwendung sinnvoll eingesetzt werden können. Gleichzeitig besitzt Miliacin aufgrund seines pflanzlichen Ursprungs Anwendungsvorteile, die sich aus der ausgezeichneten Verträglichkeit ergeben.The use of natural products in cosmetics is nowadays on the Prevention of age-related skin lesions and strengthening of the Regeneration processes of the skin directed. The exact one Mechanism of action of these substances is not guaranteed proven. Rather, they are application experiences and Analogies derived from other organ systems that for selecting a natural substance in a cosmetic preparation the Rash. Due to the fact that millet extracts and namely the active ingredient, miliacin, in animal experiment one Promoting effect on wound healing has shown us to be the assumption that, in detail so far not clarified, Properties also useful in cosmetic applications can be. At the same time has Miliacin due to his of plant origin application advantages resulting from the excellent compatibility.
Miliacin kann aus geschälter, ungeschälter Hirse, oder aus Hirsespelzen durch übliche Extraktionsverfahren hergestellt werden, wie dies nach stehend erläutert wird.Miliacin can be made from peeled, unpeeled millet, or from millet husks be prepared by conventional extraction methods, as according to is explained standing.
In den lokal anzuwendenden Zubereitungen können folgende Miliacin haltige Wirkstoffe eingesetzt werden:In the preparations to be used locally, the following miliacin containing active ingredients are used:
- a) gereinigtes oder rohes Miliacina) purified or crude miliacin
- b) filtrierte, oder nicht filtrierte Extrakte (= Hirseöl) aus Hirsefrüchten- oder Spelzen.b) filtered, or unfiltered extracts (= millet oil) from millet or husks.
Der Einsatz von reinem Miliacin und unfiltriertem Hirseöl allein, oder mit üblichen pharmazeutischen, oder kosmetischen Wirk- und Hilfsstoffen wird bevorzugt.The use of pure Miliacin and unfiltered millet oil alone, or with conventional pharmaceutical or cosmetic active and Excipients is preferred.
In den Hirsefrüchten- oder Spelzen liegt der Miliacingehalt bei ca. 0,08-0,15%. Außerdem enthalten die Früchte ca. 2,5-4,0% und die Spelzen ca. 1,5-3,0% fettes Öl, das bei der Extraktion mitgewonnen wird. Nach der Extraktion mit einem mittel- oder nichtpolarem Lösungsmittel und Ent fernen des Lösungsmittels verbleibt ein Gemisch von Hirseöl mit Miliacin und anderen Bestandteilen. Miliacin ist schwer öllöslich und fällt aus dem Hirseöl größtenteils aus.In the millet or husks miliacea content is about 0.08-0.15%. In addition, the fruits contain about 2.5-4.0% and the husks about 1.5-3.0% fat oil, which is collected during the extraction. After Extraction with a medium or non-polar solvent and Ent far from the solvent remains a mixture of millet oil with Miliacin and other components. Miliacin is highly oil-soluble and precipitates the millet oil mostly from.
Ein filtriertes, klares Hirseöl enthält somit nur ca. 0,05-0,30% Miliacin. Ein unfiltriertes Hirseöl stellt eine ölige Suspension mit ca. 2,5-4,5% Miliacin dar.A filtered, clear millet oil thus contains only about 0.05-0.30% miliacin. An unfiltered millet oil provides an oily suspension with approx. 2.5-4.5% Miliacin
Verständlicherweise läßt sich Miliacin auch nach der Hydrolyse des Hir seöls aus dem unverseifbarem Anteil gewinnen. Understandably, miliacin can also be after the hydrolysis of Hir win oil from the unsaponifiable share.
Miliacin ist ein Triterpen mit nachfolgend abgebildeter Struktur. Diese Struktur ist als 3-β-Methoxygermanicen, oder 3-β-Methoxy-δ¹⁸-oleanen zu bezeichnen.Miliacin is a triterpene with the structure depicted below. These Structure is as 3-β-Methoxygermanicen, or 3-β-methoxy-δ¹⁸-oleanen to describe.
Reines Miliacin sind weiße, geruchlose Kristalle mit einem Schmelzpunkt von 285-286°C.Pure Miliacin are white, odorless crystals with a melting point of 285-286 ° C.
MS, NMR und IR-Untersuchungen haben für Miliacin zwei Formen be schrieben. Diese unterscheiden sich in der Geometrie und optischen Ei genschaften. Beide Formen können erfindungsgemäß gemischt, oder al lein eingesetzt werden.MS, NMR and IR studies have two forms for miliacin wrote. These differ in geometry and optical egg properties. Both forms can be mixed according to the invention, or al be used.
Die aufgeführten Miliacin-haltigen Wirkstoffe können in unterschiedli che galenische Formen verarbeitet werden. Die gewählte Rezeptur hängt von der Anwendung ab.The listed miliacin-containing agents may differ in galenic forms are processed. The chosen recipe depends from the application.
Nachfolgend sind einige Beispiele für diese Formulierungen aufgeführt.Below are some examples of these formulations.
Miliacin wurde als Futterzusatz bei Mastrindern beschrieben. Im Ver gleich zu Kontrolle nahmen die Versuchstiere um 10% an Gewicht zu (A.S. No. 414994, UdSSR, No. 6, 1974).Miliacin has been described as a feed additive for cattle. In the Ver immediately after control, the experimental animals increased by 10% in weight (A.S.No.414994, USSR, No. 6, 1974).
Die Literatur (Nuzov, B.G., Patol. fiziol. eksp. Ter. (1990 Nov.-Dez.), (6), S. 51-63) beschreibt Verwendung von Hirseöl bei der Behandlung von eiternden Wunden (an Kaninchen), erwähnt aber keine kosmetische Anwendung von Miliacin oder Hirseöl am Menschen. In der verfügbaren Literatur findet sich kein Hinweis auf eine Anwendung von Hirseöl, oder Miliacin, im kosmetischen Bereich. The literature (Nuzov, B.G., Patol, fiziol, eksp., Ter. (1990 Nov.-Dec.), (6), pp. 51-63) describes use of millet oil in the treatment of festering wounds (on rabbits), but mentions no cosmetic Use of Miliacin or millet oil in humans. In the available Literature finds no indication of an application of millet oil, or Miliacin, in the cosmetic field.
Die als Kosmetika verwendeten Mittel unterscheiden sich in ihrem kolloidchemischen Aufbau und Zusammensetzung. Die kolloidchemische Systematik teilt Externa in:The cosmetics used differ in theirs colloid chemical composition and composition. The colloid chemical Systematics divides Externa into:
- 1. Flüssige Zubereitungen1. Liquid preparations
- 1.1 Lösungen1.1 solutions
- 1.2 Emulsionen1.2 emulsions
- 1.3 Suspensionen1.3 suspensions
- 2. Halbfeste Systeme2. Semi-solid systems
- 2.1 Wasserfreie Systeme - Salben und Gele2.1 Anhydrous systems - ointments and gels
- 2.2 Wasserhaltige Systeme2.2 Hydrous systems
- 2.2.1 Hydrogele2.2.1 Hydrogels
- 2.2.2 o/w Creme2.2.2 o / w cream
- 2.2.3 w/o Creme2.2.3 w / o cream
- 2.2.4 Liposomen2.2.4 Liposomes
- 3. Pulverförmige Systeme3. Powdered systems
Die Rezepturen der topisch angewandten Mittel enthalten folgende, in der Funktion unterschiedliche Bestandteile:The formulations of topically applied remedies contain the following, in the function different components:
- - Fette- fats
- - Wasser- Water
- - Emulgator/Coemulgator- emulsifier / coemulsifier
- - Stabilisator/KonsistenzgeberStabilizer / bodying agent
- - Feuchthaltemittel- Humectants
- - Antioxidant- Antioxidant
- - Konservierung- Conservation
- - u. a. Stoffe, wie z. B. Parfümierung.- u. a. Substances such. B. perfuming.
Erfindungsgemäß werden als Wirkstoffe Miliacin oder miliacinhaltige Öle mit heilungsfördernden Eigenschaften, zusammen mit den vorstehenden pharmazeutischen Hilfsstoffen angewendet. Als Emulgator können anionaktive, kationaktive, amphotere, sowie nichtionische Stoffe verwendet werden. Beispiele sind vorwiegend die Emulgatoren der letztgenannten Gruppe, die von den Fettsäureestern oder Sorbitanfettsäureestern abgeleitet sind. Als Stabilisatoren besonders der w/o-Formulierungen dienen neutrale Salze wie NaCl, oder MgSO₄. Als feuchtigkeitsgebende Mittel werden im allgemeinen mehrwertige Alkohole wie Sorbit oder Glycerin eingesetzt. In den Rezepturbeispielen enthaltene Antioxidanzien gehören der Stoffklassen der Tocopherole, oder Ascorbate an. Diese Bestandteile schützen die ungesättigten Fettsäuren vor Oxidation - "ranzig werden".According to the invention as active ingredients miliacin or miliacinhaltige Oils with healing properties, together with the applied above pharmaceutical excipients. As an emulsifier may be anionic, cationic, amphoteric, as well as nonionic substances be used. Examples are predominantly the emulsifiers of the latter group derived from the fatty acid esters or Sorbitan fatty acid esters are derived. As stabilizers especially the w / o formulations serve neutral salts such as NaCl, or MgSO₄. When Moisturizers are generally polyvalent Alcohols such as sorbitol or glycerol used. In the recipe examples contained antioxidants belong to the substance classes of tocopherols, or ascorbate. These ingredients protect the unsaturated ones Fatty acids from oxidation - "become rancid".
Alle wasserhaltige Emulsionssysteme bilden eine gute Grundlage für ei nen Keimwachstum. Nur wenn die Wasserquantität- oder -aktivität her abgesetzt wird, kann in der Rezeptur auf die Konservierungsmittel ver zichtet werden. Für die nachfolgenden Rezepturbeispiele wurden Kon servierungsmittel mit geringem Allergiepotential ausgesucht.All water-based emulsion systems form a good basis for egg Nuclear growth. Only when the water quantity or activity is forth can be discontinued in the recipe on the preservatives ver be canceled. For the following recipe examples, Kon Serving selected with low allergy potential.
Die Form von Hydrogelen auf der anorganischen Basis (SiO₂, Bentonite u. a.), oder mit organischen Gelbildnern (Alginate, Cellulosederivate, Acrylate u. a.) ist besonders bei der Behandlung von größeren Hautflächen sinnvoll.The form of hydrogels on the inorganic base (SiO₂, bentonite u. a.), Or with organic gelling agents (alginates, cellulose derivatives, Acrylates and a.) is especially in the treatment of larger Skin surfaces useful.
Allen o. g. Zubereitungen können Miliacin in einer Gewichtsmenge (bezogen auf die Gesamtzubereitung) von 0,001 bis 10,0%, vorzugsweise von 0,05 bis 3,0% enthalten. Bei Anwendung auf einer Hautfläche von ca. 10 cm² werden diese Zubereitungen in einer Gewichtsmenge von ca. 0,1-5,0 g, vorzugsweise von 0,3-2,0 g pro Anwendung (üblicherweise 1× täglich) verabreicht.Allen o. G. Preparations may contain Miliacin in a weight amount (based on the total preparation) from 0.001 to 10.0%, preferably from 0.05 to 3.0%. When applied to a skin area of About 10 cm², these preparations are in a weight of about 0.1-5.0 g, preferably 0.3-2.0 g per application (usually 1 × daily).
Erfindungsgemäß wurde festgestellt, daß diese Zubereitungen bei der Applikation beim Menschen neben Verbesserung der Hautfeuchtigkeit und Elastizität auch den Alterungsvorgängen in der Haut entgegenwirken.According to the invention, it was found that these preparations in the Human application in addition to improvement of skin moisture and elasticity also the aging processes in the skin counteract.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE1995108628 DE19508628A1 (en) | 1995-03-07 | 1995-03-07 | Skin moisturising cosmetics |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE1995108628 DE19508628A1 (en) | 1995-03-07 | 1995-03-07 | Skin moisturising cosmetics |
Publications (1)
Publication Number | Publication Date |
---|---|
DE19508628A1 true DE19508628A1 (en) | 1996-09-12 |
Family
ID=7756299
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE1995108628 Withdrawn DE19508628A1 (en) | 1995-03-07 | 1995-03-07 | Skin moisturising cosmetics |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE19508628A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3004947A1 (en) * | 2013-04-26 | 2014-10-31 | Hitex | ASSOCIATION OF MILIACIN AND POLAR LIPIDS, IN PARTICULAR SPHINGOLIPIDS AND / OR PHOSPHOLIPIDS, FOR THE CARE OF HAIR AND SCALP |
-
1995
- 1995-03-07 DE DE1995108628 patent/DE19508628A1/en not_active Withdrawn
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3004947A1 (en) * | 2013-04-26 | 2014-10-31 | Hitex | ASSOCIATION OF MILIACIN AND POLAR LIPIDS, IN PARTICULAR SPHINGOLIPIDS AND / OR PHOSPHOLIPIDS, FOR THE CARE OF HAIR AND SCALP |
EP2821052A1 (en) * | 2013-04-26 | 2015-01-07 | Hitex | Combination of miliacin and polar lipids, in particular of sphingolipids and/or phospholipids, for care of the hair and scalp |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69523805T2 (en) | Cosmetic or dermatological composition containing an alpha-hydroxy acid, salicylic acid and a retinoid | |
EP0556660B1 (en) | Utilisation of fatty alpha-hydroxy acids | |
DE69313073T2 (en) | LANOLIN FATTY ACID, YOUR SEPARATION, AND COSMETIC AND EXTERNAL APPLICATION | |
DE3930638A1 (en) | CONNECTIONS AGAINST EXCESSIVE SWEATING | |
DE3634152C2 (en) | Novel cosmetic or dermatological compositions rich in triglycerides and in free or salt form, essential fatty acids | |
WO2019238968A1 (en) | Cosmetic preparation against acne | |
CH627645A5 (en) | Cosmetic composition for smoothing the skin | |
DE69025206T2 (en) | USE OF AROMATIC BENZOATS AS DEODORANTS | |
EP0231777B1 (en) | Moist keeping cosmetics and their use | |
DE69926881T2 (en) | PREPARATIONS FOR ACNE TREATMENT | |
DE4238869C2 (en) | Agents for the treatment of atopic eczema and other inflammatory skin diseases | |
DE69727239T2 (en) | UP TO 1% FLAVONOID EXTRACT BY GINGKO BILOBA WITH CERAMIDES FOR ORAL HYGIENE AND COMPOSITIONS THEREOF | |
DE69402826T2 (en) | COMPOSITION FOR HAIR CARE | |
DE69904454T2 (en) | TOPICAL FORMULATIONS OF THE OIL-IN-WATER TYPE AS A CARRIER FOR GIVING A REDUCED IRRITATION EFFECT | |
CH667386A5 (en) | SKIN CARE COMPOSITIONS WITH CERATOLYTIC AND ANTI-INFLAMMATORY EFFECT. | |
EP0129014A1 (en) | Deodorizing cosmetic composition | |
DE69736678T2 (en) | DERMATOLOGICAL COMPOSITIONS | |
DE69010680T2 (en) | Skin bleaching cosmetics. | |
DE19508628A1 (en) | Skin moisturising cosmetics | |
DE68918280T2 (en) | COSMETIC COMPOSITION BASED ON CHROMO-CARBOXYLATE. | |
WO1993002660A1 (en) | Emulsifier concentrates | |
DE1492023C3 (en) | Skin care products | |
LU84918A1 (en) | HAIR GROWTH AGENT | |
DE4403989B4 (en) | Pharmaceutical and / or cosmetic composition and the use of such a composition | |
DE69320638T2 (en) | TOPICAL AGENT |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8139 | Disposal/non-payment of the annual fee |